GiantCRO is a Full Service contract research organization, one of leading CROs in China. Founded in 2001, GiantCRO is one of the CRO found earliest in China. GiantCRO is growing rapidly and streadily with its head-office in Beijing, several branch offices in Shanghai, Wuhan, Xian, Shenyang, Changsha, Guangzhou, contact offices in U.S, England, Germany, Australia and Japan.

Tenet of the Company

People orientation, quality-based success, efficiency first,   the best of   the best

Culture of the Company

Always self-improvement, ceaseless innovation, sincere   cooperation,  benefit to society

-Clinical researches on more than 150 drugs (*including 15 category I novel drugs)

-More than 100 clinical researches on medical instruments (* involving 21 professional fields, such as heart stent, intracranial stent, orthopedics, plastic surgery, dialysis products, organ transplantation, etc)

-Participated in the whole process of CHANCE research initiated by Professor Wang Yongjun from subject declaration to its publication on New England Journal of Medicine, which changed the global treatment guideline for cerebral apoplexy.

-Clinical trial of Aildenafil 2016 passed successfully 7.22 audit and CDE review

GiantCRO takes oath to grow-up with the leadership in specialized service for drug research and development in pharmaceutical market. We never follow others. We are engaged always in self improvement, ceaseless innovation, sincere cooperation and benefit to society. We believe in that faith moves mountains. 

Talented person is the foundation of our success. We have formed a group that is brave, confident and good at exploitation, providing a broad arena for employees, endowing them with sacred responsibilities and giving them generous rewards. We have created a working environment characterized in sincere cooperation, mutual sympathy, seeking talents and empowerment of personnel, in order to achieve the goals impossible to achieve individually. We are united as one, realizing dreams of our customers, personnel and shareholders through unremitting efforts.

Our customers are our source of development. We are developing our customers worldwide and providing specialized solutions and meticulous services for them. We are engaged in improving the operating efficiency of medical industry, creating values for our customers beyond their requirement, and eventually benefiting society.

  • Leaders
  • Expert
  • Haibo Wu
    Graduated from Peking University Health Science Center in 1994, he was engaged in clinical works in Peking Universith Third Hospital and Sixth Hospital successively. Responsible for executing the Board resolution, company development direction, important issues, engaged in general business promotion and communication both domestic and abroad.
  • Yanan Liu
    Graduated from Peking University Health Science Center in 1983, and then graduated from School of Social Sciences Department of Tsinghua University in 1986. as Programmer, DBA, System Architect and IT Director in Highland Capital Brokerage, Excellence Sales Center Manager and global account manager in Microsoft (China), Vice President of Siemens (China) , CEO of Siemens (China) Information Group, CEO of Atos Worldline (China) Co.,Ltd, CEO and Executive Director of GiantCRO.
  • Shaoqiang Chen
    Graduated from Western Languages Department of Peking University,Professor, Information Center of CFDA,General Manager for platform of product introduction and commercialization, GiantCRO
  • Hao Li
    Graduated from Peking University Health Science Center, and Statistics Ph.D. in Kentucky University in U.S.A. Visiting Professor of Beijing Tian tan Hospital. Responsible for establishing clinical Big Data and medical support for GiantCRO.
  • Xia Chen
    In 1986, graduated from Capital Medical University. Clinical practice for years, Beijing Tongren Hospital. In GiantCRO, in charge of business related to pharmaceutical affairs/administration & quality surveillance on Company’s business operation.
  • Changsheng Ma
    Director of Cardiology Department, Beijing Anzhen Hospital, Capital Medical University, Professor, Chief Doctor and Ph.D. supervisor.
  • Xin Ma
    President of Beijing Anding Hospital, Capital Medical University, Professor and CCP member.
  • Yongjun Wang
    Vice President of Tiantan Hospital, Capital Medical University, Professor, Chief Doctor and Ph.D. supervisor.
  • Linong Ji
    Director of Endocrinology Department of Peking University People’s Hospital.
  • Tianmei Si
    Director of Clinical Psychological Pharmacology Research Office of Psychological Health Institute of Beijing University.
  • Mingyu Ni
    Capital Medical University Resources Management Office of the Secretary of clinical samples
  • Hui Zhuang
    Academician of Chinese Academy of Engineering (Virologist), epidemiological and microbiological expert, and Academician of Chinese Academy of Engineering (Virologist).
  • Jiabang Sun
    Chief consultant, professor
  • Xiangmei Chen
    Chief consultant, professor, doctoral supervisor, and Academician of Chinese Academy of Engineering.
  • Dayi Hu
    Headmaster of cardiovascular Institute of People's Hospital of Peking University
  • Defang Zhong
    Chinese Academy of Sciences, Shanghai Institute of Materia Medica researcher, director of Research Center for drug metabolism, Chinese Academy of Sciences, Shanghai Institute of Materia Medica, director of the center for drug metabolism research.
  • Haitao Zhao
    Peking Union Medical College Hospital, chief physician of liver surgery.